Intelligence
Latest
Intel
Intel
Intel
Intel
Paris-based private equity firm Andera Partners has agreed to sell its portfolio company, Amolyt Pharma, a global biopharmaceutical company specialising in developing therapeutic peptides for rare endocrine and related diseases, to British-Swedish multinational pharma AstraZeneca, in a deal worth up to $1.05bn.
- 14/03/2024
Awards
Intel
Intel
Intel
Private equity firms can capitalise on opportunities for modernisation, digitalisation and consolidation in the wealth management sector, according to Christian Kent, a Managing Director in global investment bank Houlihan Lokey’s fintech group, who last month advised on CBPE Group’s sale of Perspective Financial Group to Charlesbank.
- 12/03/2024
Intel
Q&A
Events
16 May, 2024 – 8:30 am
16 May, 2024 – 5:30 pm
12 September, 2024 – 8:30 am
24 October, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am